IL312165A - New methods - Google Patents
New methodsInfo
- Publication number
- IL312165A IL312165A IL312165A IL31216524A IL312165A IL 312165 A IL312165 A IL 312165A IL 312165 A IL312165 A IL 312165A IL 31216524 A IL31216524 A IL 31216524A IL 312165 A IL312165 A IL 312165A
- Authority
- IL
- Israel
- Prior art keywords
- 6alkyl
- reversing
- independently selected
- treating
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163262732P | 2021-10-19 | 2021-10-19 | |
| PCT/US2022/078177 WO2023069880A1 (en) | 2021-10-19 | 2022-10-14 | Novel methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL312165A true IL312165A (en) | 2024-06-01 |
Family
ID=86058575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL312165A IL312165A (en) | 2021-10-19 | 2022-10-14 | New methods |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240415832A1 (https=) |
| EP (1) | EP4419523A4 (https=) |
| JP (1) | JP2024539106A (https=) |
| KR (1) | KR20240089771A (https=) |
| CN (1) | CN118556058A (https=) |
| AU (1) | AU2022368858A1 (https=) |
| CA (1) | CA3235356A1 (https=) |
| IL (1) | IL312165A (https=) |
| MX (1) | MX2024004725A (https=) |
| WO (1) | WO2023069880A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3898580A4 (en) | 2018-12-17 | 2022-08-10 | Intra-Cellular Therapies, Inc. | SYNTHESIS OF CONDENSED GAMMA-CARBOLINES WITH SUBSTITUTED HETEROCYCLE |
| IL283963B2 (en) | 2018-12-17 | 2025-01-01 | Intra Cellular Therapies Inc | Synthesis of condensed gamma-carbolines and converted heterocycles |
| WO2020132605A1 (en) | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2024194263A1 (en) | 2023-03-17 | 2024-09-26 | Norwegian University Of Life Sciences | Serotonin 5ht2a receptor antagonist for use in treating side effects resulting form mu opioid receptor agonist overdose |
| WO2026011136A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2026011166A1 (en) * | 2024-07-03 | 2026-01-08 | Intra-Cellular Therapies, Inc. | Substituted heterocycles for use in the treatment of diseases involving the 5-ht2a receptor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7223742B2 (ja) * | 2017-07-26 | 2023-02-16 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| US20220160704A2 (en) * | 2018-08-08 | 2022-05-26 | Torralva Medical Therapeutics Llc | Compositions for opiate and opioid prevention and reversal, and methods of their use |
| WO2020132605A1 (en) * | 2018-12-21 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compounds |
| CN118105390A (zh) * | 2019-01-23 | 2024-05-31 | 细胞内治疗公司 | 治疗成瘾的方法 |
| CA3139168A1 (en) * | 2019-05-07 | 2020-11-12 | Nirsum Laboratories, Inc. | Opioid receptor antagonist prodrugs |
| EP4493560A4 (en) * | 2022-03-14 | 2026-03-18 | Intra Cellular Therapies Inc | ORGANIC COMPOUNDS |
-
2022
- 2022-10-14 MX MX2024004725A patent/MX2024004725A/es unknown
- 2022-10-14 KR KR1020247016018A patent/KR20240089771A/ko active Pending
- 2022-10-14 US US18/703,145 patent/US20240415832A1/en active Pending
- 2022-10-14 IL IL312165A patent/IL312165A/en unknown
- 2022-10-14 JP JP2024523484A patent/JP2024539106A/ja active Pending
- 2022-10-14 EP EP22884603.6A patent/EP4419523A4/en active Pending
- 2022-10-14 CA CA3235356A patent/CA3235356A1/en active Pending
- 2022-10-14 WO PCT/US2022/078177 patent/WO2023069880A1/en not_active Ceased
- 2022-10-14 AU AU2022368858A patent/AU2022368858A1/en active Pending
- 2022-10-14 CN CN202280084050.5A patent/CN118556058A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240415832A1 (en) | 2024-12-19 |
| JP2024539106A (ja) | 2024-10-28 |
| EP4419523A1 (en) | 2024-08-28 |
| CN118556058A (zh) | 2024-08-27 |
| KR20240089771A (ko) | 2024-06-20 |
| MX2024004725A (es) | 2024-05-10 |
| CA3235356A1 (en) | 2023-04-27 |
| AU2022368858A1 (en) | 2024-05-02 |
| EP4419523A4 (en) | 2025-09-17 |
| WO2023069880A1 (en) | 2023-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL312165A (en) | New methods | |
| RU2320657C2 (ru) | Новые производные пирролидиния | |
| JP2014500295A5 (https=) | ||
| JP2018515495A5 (https=) | ||
| JP2006524222A5 (https=) | ||
| JP2011509301A5 (https=) | ||
| RU94044671A (ru) | Применение непептидных антагонистов рецептора тахикинина | |
| KR20130045241A (ko) | 구토방지제로서의 아미설프라이드의 용도 | |
| JP2006504766A5 (https=) | ||
| CA2810092A1 (en) | Deuterated analogs of pridopidine useful as dopaminergic stabilizers | |
| AR089768A1 (es) | Compuestos terapeuticamente activos y sus metodos de uso | |
| JP2003506354A5 (https=) | ||
| RU2011136250A (ru) | Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство | |
| MX2021014372A (es) | Compuestos derivados de 1,3,4-oxadiazol como inhibidores de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos. | |
| AU2015288381B2 (en) | Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anti-cancer ingredient, pharmaceutical composition, medicinal preparation, method for treating prostate cancer | |
| UA126788C2 (uk) | Комплексні сполуки, що містять макроциклічне кільце пентаази, які мають пероральну біодоступність | |
| CA2303815A1 (en) | N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain | |
| JP2006519852A5 (https=) | ||
| JP2011509302A5 (https=) | ||
| RU2020121162A (ru) | Противоопухолевый агент | |
| JP2010506919A5 (https=) | ||
| JP2013528659A5 (https=) | ||
| CN102746292B (zh) | 环化的小檗碱衍生物及其制备方法和用途 | |
| TWI254706B (en) | Cyclic amine compounds and pharmaceutical composition containing the same | |
| JPH02502185A (ja) | 咳および気管支収縮の治療用５‐ｈｔ３レセプター拮抗物質 |